Delve Insight Market Research Reports

TITLE Actions
STAT Inhibitors - Pipeline Insight, 2020
Published in Nov 2020 | US $ 2500 Onwards | By Delve Insight

DelveInsight’s, “STAT Inhibitors – Pipeline Insight, 2020,” report provides comprehensive insights about 60+ companies and 60+ pipeline drugs based on STAT Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and no...

Histone deacetylase (HDAC) Inhibitors - Pipeline Insight, 2020
Published in Nov 2020 | US $ 2500 Onwards | By Delve Insight

DelveInsight’s, “Histone deacetylase (HDAC) Inhibitors– Pipeline Insight, 2020,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Histone deacetylase (HDAC) Inhibitors pipeline landscape. It covers the pipeline dru...

Endometriosis - Pipeline Insight, 2020
Published in Nov 2020 | US $ 2500 Onwards | By Delve Insight

DelveInsight’s, “Endometriosis – Pipeline Insight, 2020,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Endometriosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinica...

Amyotrophic lateral sclerosis - Pipeline Insight, 2020
Published in Nov 2020 | US $ 3000 Onwards | By Delve Insight

DelveInsight’s, “Amyotrophic lateral sclerosis – Pipeline Insight, 2020,” report provides comprehensive insights about 250+ companies and 250+ pipeline drugs in Amyotrophic lateral sclerosis pipeline landscape. It covers the pipeline drug profiles, i...

YSELTY (LINZAGOLIX; OBE2109) - Emerging Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 3250 Onwards | By Delve Insight

“YSELTY (LINZAGOLIX; OBE2109) - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Endometriosis in 7 Major Markets. A detailed picture of the YSELTY (LINZAGOLIX; OBE2109)...

VEBICORVIR (ABI-H0731) - Emerging Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 3250 Onwards | By Delve Insight

“VEBICORVIR (ABI-H0731)- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Hepatitis B in 7 Major Markets. A detailed picture of the VEBICORVIR (ABI-H0731) in Seven Major...

Selgantolimod (GS-9688) - Emerging Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 3250 Onwards | By Delve Insight

“Selgantolimod (GS-9688) - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Hepatitis B in 7 Major Markets. A detailed picture of the SELGANTOLIMOD (GS-9688) in Seven Major M...

RELUGOLIX (TAK-385) - Emerging Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 3250 Onwards | By Delve Insight

“RELUGOLIX (TAK-385) - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Endometriosis in 7 Major Markets. A detailed picture of the RELUGOLIX (TAK-385) in Seven Major Markets...

GSK3228836- Emerging Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 3250 Onwards | By Delve Insight

“GSK3228836- Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Hepatitis B in 7 Major Markets. A detailed picture of the GSK3228836 in Seven Major Markets, i.e., United S...

Evobrutinib (M2951) - Emerging Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 3250 Onwards | By Delve Insight

“Evobrutinib (M2951) - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Rheumatoid Arthritis in 7 Major Markets. A detailed picture of the EVOBRUTINIB (M2951) in Seven M...

Tenofovir Disoproxil- Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 2750 Onwards | By Delve Insight

“Tenofovir disoproxil- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Tenofovir disoproxil in Seven Major ...

Tenofovir Alafenamide- Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 2750 Onwards | By Delve Insight

“Tenofovir alafenamide- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Tenofovir alafenamide in Seven Majo...

Orilissa (Elagolix) - Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 2750 Onwards | By Delve Insight

“Orilissa (Elagolix)- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Orilissa (Elagolix) in Seven Major Ma...

Mavyret- Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 2750 Onwards | By Delve Insight

“Mavyret- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Mavyret in Seven Major Markets, i.e., United Stat...

Harvoni- Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 2750 Onwards | By Delve Insight

“Harvoni- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Harvoni in Seven Major Markets, i.e., United Stat...

Epclusa- Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 2750 Onwards | By Delve Insight

“Epclusa- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Epclusa in Seven Major Markets, i.e., United Stat...

Entecavir- Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 2750 Onwards | By Delve Insight

“Entecavir- Drug Insight and Market Forecast – 2030” report by DelveInsight outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Entecavir in Seven Major Markets, i.e., United ...

Otilimab (GSK3196165) - Emerging Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 2750 Onwards | By Delve Insight

“Otilimab (GSK3196165) - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Rheumatoid Arthritis in 7 Major Markets. A detailed picture of the OTILIMAB (GSK3196165) in Sev...

Olokizumab - Emerging Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 3250 Onwards | By Delve Insight

“Olokizumab - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Rheumatoid Arthritis in 7 Major Markets. A detailed picture of the OLOKIZUMAB in Seven Major Markets, i.e....

Filgotinib - Emerging Drug Insight And Market Forecast – 2030
Published in Oct 2020 | US $ 3250 Onwards | By Delve Insight

“Filgotinib - Emerging Drug Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Rheumatoid Arthritis in 7 Major Markets. A detailed picture of the FILGOTINIB in Seven Major Markets, i.e....

We are on:

Need Help?

Buy Any Report Avail 20% Discount. Coupon Code: DEC20